Rapid Development of Modified Vaccinia Virus Ankara (MVA)-Based Vaccine Candidates Against Marburg Virus Suitable for Clinical Use in Humans

Background/Objectives: Marburg virus (MARV) is the etiological agent of Marburg Virus Disease (MVD), a rare but severe hemorrhagic fever disease with high case fatality rates in humans. Smaller outbreaks have frequently been reported in countries in Africa over the last few years, and confirmed huma...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Alina Tscherne, Georgia Kalodimou, Alexandra Kupke, Cornelius Rohde, Astrid Freudenstein, Sylvia Jany, Satendra Kumar, Gerd Sutter, Verena Krähling, Stephan Becker, Asisa Volz
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-11-01
coleção:	Vaccines
Assuntos:	Modified Vaccinia virus Ankara (MVA) viral vector vaccine emerging viruses rapid vaccine development Marburg virus
Acesso em linha:	https://www.mdpi.com/2076-393X/12/12/1316
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!